Advertisement
Screener

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

PROVECTUS BIOPHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.38 per share for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-31.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2017-03-31

  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2015 was $0.38, a 50.65% decline from fiscal 2014.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2014 was $0.77, a 35.09% increase from fiscal 2013.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2013 was $0.57, a 21.92% decline from fiscal 2012.
  • PROVECTUS BIOPHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2012 was $0.73, a 6.41% decline from fiscal 2011.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month
2015-12-31$0.38
10-K · filed 2017-03-31
2014-12-31$0.77
10-K · filed 2017-03-31
2014-09-30$0.77
10-Q · filed 2014-11-06
2013-12-31$0.57
10-K · filed 2016-03-30
2012-12-31$0.73
10-K · filed 2015-03-12
2011-12-31$0.78
10-K · filed 2014-03-13
2010-12-31$0.88
10-K · filed 2013-03-14